中通快遞(2057.HK)首日上市高開11.93% 市值2070億港元
格隆匯9月29日丨中通快遞(2057.HK)今日首日上市高開11.93%報244港元,盤前成交1.68億港元,最新總市值2070億港元。該股IPO定價218港元,獲6.69倍認購,國際發售獲大幅超額認購,公司所得款項總額約98.1億港元。中通快遞於2002年成立,按總包裹量計是中國領先的快遞服務供應商,2019年市佔率為19.1%,在通達系中規模最大,盈利能力最強。招股書顯示,公司2017財年至2019財年總收益年複合增長率為19.18%,淨利潤年複合增長率為21.54%。此次中通快遞在港上市成為繼小米、美團、阿里巴巴、京東之後,第五家以同股不同權架構上市的企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.